Navigation Links
NeuroQuant®, CorTechs Labs' FDA-Cleared System for Quantifying Regional Brain Atrophy from MRIs, Used to Identify Patients at Highest Risk for Developing Dementia
Date:10/12/2011

LA JOLLA, Calif., Oct. 12, 2011 /PRNewswire/ -- A ground-breaking paper published online today (Heister, Brewer, Magda, Blennow & McEvoy, for the Alzheimer's Disease Neuroimaging Initiative, 2011, Predicting MCI Outcome with Clinically Available MRI and CSF Biomarkers, Neurology, epub ahead of print) compared the ability of three clinically available measures to predict the onset of dementia: i) degree of memory impairment,  ii) degree of atrophy in the medial temporal lobe of the brain as measured by NeuroQuant®, and iii) levels of peptides in cerebrospinal fluid that are associated with Alzheimer's disease.  It reported that quantitative atrophy measurement significantly improved prediction of future dementia onset in elderly individuals with memory complaints.

According to Dr. Linda McEvoy, from the Department of Radiology at the University of California, San Diego (UCSD) and senior author of the report: "When these risk factors were examined separately, individuals positive on any one risk factor showed higher risk of developing dementia than individuals testing negative on that factor. More importantly, the joint presence of any two risk factors substantially increased risk. In fact 85% of patients with both higher memory impairment and medial temporal atrophy became demented within 3 years, whereas only 5% of those testing negative on both criteria did. Of the three measures, the presence of atrophy predicted the fastest rate of decline."

Dr. James Brewer, another study co-author who is a neurologist and faculty member at UCSD, indicated that: "Ongoing heart damage can be detected with physical markers, but no such measure has existed for brain degeneration. This paper shows that we now can look directly at the brain using MRI and NeuroQuant® to determine if critical structures are degenerating. At UCSD, we have been using this tool clinically for more than three years and it has fundamentally changed the way that patients are assessed and managed. In individuals without neurodegeneration, the search for other causes can be curative; in individuals with neurodegeneration, education and preparation is facilitated by the more accurate assessment."

The FDA-cleared NeuroQuant® system is "intended for automatic labeling, visualization and volumetric quantification of segmentable brain structures from a set of MR images". Using scans routed from a scanner or PACS as input, it can return age-related statistical atrophy reports and numerical and color-blended anatomical volumes to most DICOM-compliant viewing devices. NeuroQuant® is already available at more than 50 leading clinical sites across the nation.

About CorTechs Labs, Inc.  CorTechs translates advanced neuroimaging research into practical clinical tools that may improve care of the millions of people suffering from neurodegenerative disorders. For more information please visit our website at www.cortechslabs.com.

CONTACT:  CorTechs Labs, Inc. +1 858 459 9700 info@cortechslabs.com


'/>"/>
SOURCE CorTechs Labs, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. GeoVax Labs, Inc. Comments on Discontinuance of Mercks HIV Vaccine Trial
2. GeoVax Labs, Inc. Third Quarter Financial Results and Operational Update
3. Study of Pathwork Diagnostics Tissue of Origin Test Published in the Journal of Molecular Diagnostics: Investigates Test Reproducibility in Multiple Labs to Determine Primary Tumor in Cancer Cases
4. GeoVax Labs, Inc. Selects Financial Relations Board as Investor Relations Counsel
5. GeoVax Labs, Inc. Selected by Georgia Bio as 2008 Deal of the Year Award Winner in Life Sciences Industry
6. GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2007 Financial Results
7. NOLabs AB Reports Success in Fight Against Bacteria Causing Urinary Tract Infection
8. Chuck Panozzo, Founder of Rock Band Styx, Joins GeoVax Labs, Inc. as an Advocate for Its HIV/AIDS Vaccine
9. GeoVax Labs, Inc. Announces Results of 2009 Annual Shareholders Meeting
10. Keep Mosquitoes and More Out of Your Yard with Garlic From Garlic Research Labs, Inc.
11. GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016 According to ... Type (Standard Pen Needles, Safety Pen Needles), Needle Length ... Growth Hormone), Mode of Purchase (Retail, Non-Retail) - Trends ... report studies the market for the forecast period of ... USD 2.81 Billion by 2021 from USD 1.65 Billion ...
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... A revolution is underway. ... ambulance transport experience for the millions of people who require these medical transport ... taxi industry through the use of technology. Now, SmartEMS has put forth an ...
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A Forever Recovery, a ... and World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is ... to some of the world’s leading providers of cereal and other breakfast foods. Its ...
(Date:6/26/2016)... ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is helping ... fitness app. The fitness app plans to fix the two major problems leading the fitness ... size fits all type program , They don’t eliminate all the reasons people ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can ... Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey ... cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , ... Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , ... our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First ...
Breaking Medicine News(10 mins):